Picture of PAION AG logo

PA8 — PAION AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: PAION announces clinical development progress with remimazolam

Nov 23 (Reuters) - PAION AG  PA8G.DE : 
    * DGAP-NEWS: PAION ANNOUNCES CLINICAL DEVELOPMENT PROGRESS WITH REMIMAZOLAM BY ITS PARTNER 
HANA 
PHARM IN SOUTH KOREA 
    * HANA PHARM PLANS TO SUBMIT A MARKETING AUTHORIZATION APPLICATION IN 2018 
 
Source text for Eikon:  ID:nEQ33GRcDa  
Further company coverage:  PA8G.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on PAION AG

See all news